Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder.

OBJECTIVE The authors used proton magnetic resonance spectroscopic imaging ((1)H-MRSI) to assess potential reductions of N-acetylaspartate (a marker of neuronal integrity) in the hippocampal area and dorsolateral prefrontal cortex of patients with schizophreniform disorder. In addition, they assessed the relationship between N-acetylaspartate levels and working memory deficits. METHOD Twenty-four patients with DSM-IV schizophreniform disorder and 24 healthy subjects were studied. Subjects underwent (1)H-MRSI and were given the N-back working memory test. RESULTS The schizophreniform disorder patients had selective reductions of N-acetylaspartate ratios in the hippocampal area and the dorsolateral prefrontal cortex, and a positive correlation was seen between N-acetylaspartate ratios in the dorsolateral prefrontal cortex and performance during the 2-back working memory condition. CONCLUSIONS Similar to findings reported in schizophrenia studies, N-acetylaspartate reductions in the hippocampal area and the dorsolateral prefrontal cortex were seen in patients with schizophreniform disorder. Moreover, the results support other evidence that neuronal pathology in the dorsolateral prefrontal cortex accounts for a proportion of working memory deficits already present at illness outset.

[1]  S. Bluml,et al.  Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by 13C MRS and [1-13C]glucose infusion , 2001 .

[2]  J. Vion-Dury,et al.  Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy , 1995, The Lancet.

[3]  R. Coppola,et al.  Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. , 1999, Cerebral cortex.

[4]  R. Lenkinski,et al.  The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons , 1995, Neuroscience Letters.

[5]  Steven Warach,et al.  Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI , 1999, Biological Psychiatry.

[6]  J A Frank,et al.  Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. , 2000, The American journal of psychiatry.

[7]  K. Bhakoo,et al.  In Vitro Expression of N‐Acetyl Aspartate by Oligodendrocytes , 2000, Journal of neurochemistry.

[8]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  W. Brooks,et al.  Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[10]  Edward E. Smith,et al.  Temporal dynamics of brain activation during a working memory task , 1997, Nature.

[11]  Raquel E Gur,et al.  Proton Magnetic Resonance Spectroscopy in the Frontal and Temporal Lobes of Neuroleptic Naive Patients with Schizophrenia , 1999, Neuropsychopharmacology.

[12]  P. Matthews,et al.  Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.

[13]  B L Hart,et al.  Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain. , 1999, Neuroreport.

[14]  K O Lim,et al.  Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. , 1998, Archives of general psychiatry.

[15]  Robert Bartha,et al.  A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients , 1999, Biological Psychiatry.

[16]  J. Clark,et al.  N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction , 1998, Developmental Neuroscience.

[17]  N. Schuff,et al.  Method to correlate 1H MRSI and 18FDG‐PET , 2000, Magnetic resonance in medicine.

[18]  Corey C. Ford,et al.  Frontal lobe of children with schizophrenia spectrum disorders: A proton magnetic resonance spectroscopic study , 1998, Biological Psychiatry.

[19]  G Tedeschi,et al.  Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. , 1996, The American journal of psychiatry.

[20]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[21]  R. Kuzniecky,et al.  Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging , 1996, Annals of neurology.

[22]  R. Coppola,et al.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.

[23]  T. Serikawa,et al.  The Effects of Lithium Chloride and Other Substances on Levels of Brain N-Acetyl-L-Aspartic Acid in Canavan Disease-Like Rats , 2002, Neurochemical Research.

[24]  D. Braus,et al.  Favorable Effect on Neuronal Viability in the Anterior Cingulate Gyrus due to Long-Term Treatment with Atypical Antipsychotics: An MRSI Study , 2001, Pharmacopsychiatry.

[25]  Peter M. G. Munro,et al.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.

[26]  M. Egan,et al.  Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. , 2000, The American journal of psychiatry.

[27]  O. Andreassen,et al.  Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice , 2000, Journal of neurochemistry.

[28]  M. Weiner,et al.  Decreased left frontal lobe N-acetylaspartate in schizophrenia. , 1997, The American journal of psychiatry.

[29]  P. Dannon,et al.  A Follow-up Study of Patients with DSM-IV Schizophreniform Disorder , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[30]  B. Hart,et al.  Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury. , 1998, AJNR. American journal of neuroradiology.

[31]  John Lauriello,et al.  Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia , 2001, Psychiatry Research: Neuroimaging.

[32]  Marc Laruelle,et al.  Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies , 2000, Psychiatry Research: Neuroimaging.

[33]  Alessandro Bertolino,et al.  The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia , 2001, Biological Psychiatry.

[34]  Dieter F. Braus,et al.  Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia , 2000, Schizophrenia Research.

[35]  P. Goldman-Rakic,et al.  The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia , 1999, Biological Psychiatry.